Transcription of INJECTABLE DRUG DELIVERY 2013: …
{{id}} {{{paragraph}}}
Example: confidence
INJECTABLE DRUG DELIVERY 2013: …
JULY 2013 ISSUE NO 43 ISSN-2049-145 XINJECTABLE drug DELIVERY 2013 :FORMULATIONS FOCUS1024_GF_ONdrugDeilvery_June Inj 11024_GF_ONdrugDeilvery_June Inj 105/07/ 2013 09:1605/07/ 2013 09:162 CONTENTSS mart Formulations of Liquid BiotherapeuticsDr Jan Jezek, Chief Scientific OfficerArecor Ltd 4-7 Using Half-Life Extension to Move a Pioneering treatment for AutoimmuneDiseases Towards Clinical TrialsDr Mark Perkins, Customer Solution Manager Novozymes Biopharma US, Inc and Dr Anne S. De Groot, Chief Executive Officer & Chief Scientific OfficerEpiVax, Inc 10-12 Self-Interaction Chromatography Lends Insight into formulation StudiesDr Michelle Amaral, Science Writer/PR ConsultantSoluble Therapeutics, Inc 14-15 Syringe Siliconisation: Trends, Methods, Analysis ProceduresClaudia Petersen, Global Director, Marketing & DevelopmentGerresheimer B nde GmbH 16-19 Copyright 2013 Frederick
www.ondrugdelivery.com ONdrugDelivery JULY 2013 ISSUE NO 43 ISSN-2049-145X INJECTABLE DRUG DELIVERY 2013: FORMULATIONS FOCUS 11024_GF_ONdrugDeilvery_June Inj Formulations.indd 1024_GF_ONdrugDeilvery_June Inj Formulations.indd 1 005/07/2013 09:165/07/2013 09:16
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Transfer Buffer Formulations, Laemmli, Buffer, Extemporaneous formulations of Oral Liquids, ADDITIVES FOR Specialty Chemistry Formulations, ADDITIVES FOR Specialty Chemistry Formulations PER FUNCTION, InnovatIve strategIes for stabIlIzatIon formulatIons, InnovatIve strategIes for stabIlIzatIon, FormulatIons, Validation of Related Substances, Validation of Related Substances Method, Development and Validation of In Vitro Release